Biogen’s top scientist nearly dares FDA not to approve Alzheimer’s drug

Biogen’s top scientist nearly dares FDA not to approve Alzheimer’s drug

By ADAM FEUERSTEIN

EMILIE PICKERING FOR STAT

Biogen’s top scientist offered unflinching support Thursday for the efficacy of the company's controversial Alzheimer’s drug called aducanumab.

READ MORE